[Downstream approaches to atrial fibrillation: the new rhythm control drugs and promising targets].
Yamashita
Toru
T
yamashitat@nissanchem.co.jp
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D015195:Drug Design; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D051666:Kv1.5 Potassium Channel / Q000037:antagonists & inhibitors / Q000502:physiology
D000889:Anti-Arrhythmia Agents; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D051666:Kv1.5 Potassium Channel